https://beacon.bio/ https://beacon.bio/landing-pages/template https://beacon.bio/404 https://beacon.bio/dreem-3s https://beacon.bio/careers https://beacon.bio/about https://beacon.bio/products-services https://beacon.bio/contact-us https://beacon.bio/mailing-list https://beacon.bio/research-partnership https://beacon.bio/setup https://beacon.bio/news https://beacon.bio/scientific-publications https://beacon.bio/open-source-software https://beacon.bio/landing-pages/template-2 https://beacon.bio/legal/cookie-policy https://beacon.bio/legal/terms-of-service https://beacon.bio/news/beacon-named-fast-companys-most-innovative-companies-2026 https://beacon.bio/news/beacon-biosignals-announces-partnership-with-harmony-biosciences-to-advance-objective-clinical-endpoints-in-hypersomnia-conditions-through-quantitative-eeg https://beacon.bio/news/beacon-biosignals-announces-multi-year-expansion-of-strategic-collaboration-with-takeda-to-advance-narcolepsy-diagnosis-and-neurobiomarker-discovery https://beacon.bio/news/beacon-biosignals-raises-86m-to-accelerate-ai-driven-insights-into-brain-health https://beacon.bio/news/beacon-biosignals-completes-strategic-transaction-to-acquire-clevemed https://beacon.bio/news/beacon-biosignals-reports-novel-sleep-eeg-results-from-multiple-industry-collaborations-at-the-american-epilepsy-society-annual-meeting https://beacon.bio/news/fda-authorizes-beacon-s-dreem-3s-as-first-sleep-wearable-with-predetermined-change-control-plan-paving-the-way-for-continuous-algorithm-enhancements-in-sleep-monitoring https://beacon.bio/news/beacon-launches-headfirst-clinical-trial-to-study-sleep-eeg-in-pediatric-developmental-disorders-partners-with-lgs-foundation https://beacon.bio/news/beacon-biosignals-announces-strategic-collaboration-with-skye-bioscience-to-integrate-sleep-quality-and-sleep-apnea-endpoints-in-cbeyond-phase-2-trial-of-nimacimab-for-obesity https://beacon.bio/news/beacon-biosignals-selected-by-longboard-pharmaceuticals-to-advance-understanding-of-epilepsy-and-related-conditions https://beacon.bio/news/beacon-biosignals-and-takeda-launch-strategic-collaboration-to-advance-neurobiomarkers-and-endpoints-for-sleep-disorders https://beacon.bio/news/beacon-biosignals-expands-sleep-analysis-capabilities-with-fda-clearance-of-sleepstageml https://beacon.bio/news/beacon-biosignals-welcomes-david-matthews-phd-as-chief-business-officer https://beacon.bio/news/syndeio-biosciences-announces-clinical-collaboration-with-beacon-biosignals-to-advance-precision-eeg-biomarkers-in-major-depressive-disorder https://beacon.bio/news/beacon-biosignals-elevates-brain-health-understanding-at-aes-2023 https://beacon.bio/news/beacon-biosignals-receives-fda-clearance-for-ai-assisted-sleep-monitoring-device-dreem-3s https://beacon.bio/news/beacon-biosignals-acquires-dreem-launches-at-home-sleep-monitoring-services-for-clinical-trials https://beacon.bio/news/beacon-biosignals-ceo-jacob-donoghue-to-speak-on-panel-at-precision-medicine-world-conference